HealthyPlace.com

HealthyPlace.com

About Us
Site Map
Help
Advertisers
Tools
Contact Us

Information

Diseases and Conditions
Psychiatric Medications
Online Psychological Tests
HealthyPlace.com Films
Mental Health Videos
Bookstore
Resource Phone Numbers

Community & Events

Bulletin Boards
Chat Rooms
Diaries - Journals
HealthyPlace.com Radio
Online Support Groups

send this page to a friend


advertisement


Depakote and Birth Defects

Important information about Depakote for women who could become pregnant

About the use of DEPAKOTE® (divalproex sodium) Tablets

Please read this leaflet carefully before you take DEPAKOTE® (divalproex sodium) tablets. This leaflet provides a summary of important information about taking DEPAKOTE to women who could become pregnant. If you have any questions or concerns, or want more information about DEPAKOTE, contact your doctor or pharmacist.

Information For Women Who Could Become Pregnant
DEPAKOTE can be obtained only by prescription from your doctor. The decision to use DEPAKOTE is one that you and your doctor should make together, taking into account your individual needs and medical condition.

Before using DEPAKOTE, women who can become pregnant should consider the fact that DEPAKOTE has been associated with birth defects, in particular, with spina bifida and other defects related to failure of the spinal canal to close normally. Approximately 1 to 2% of children born to women with epilepsy taking DEPAKOTE in the first 12 weeks of pregnancy had these defects (based on data from the Centers for Disease Control, a U.S. agency based in Atlanta). The incidence in the general population is 0.1 to 0.2%.

Information For Women Who Are Planning to Get Pregnant

  • Women taking DEPAKOTE who are planning to get pregnant should discuss the treatment options with their doctor.

Information For Women Who Become Pregnant While Taking DEPAKOTE

  • If you become pregnant while taking DEPAKOTE you should contact your doctor immediately.

Other Important Information About DEPAKOTE Tablets

  • DEPAKOTE tablets should be taken exactly as it is prescribed by your doctor to get the most benefits from DEPAKOTE and reduce the risk of side effects.
  • If you have taken more than the prescribed dose of DEPAKOTE, contact your hospital emergency room or local poison center immediately.
  • This medication was prescribed for your particular condition. Do not use it for another condition or give the drug to others.

Facts About Birth Defects
It is important to know that birth defects may occur even in children of individuals not taking any medications or without any additional risk factors.

This summary provides important information about the use of DEPAKOTE to women who could become pregnant. If you would like more information about the other potential risks and benefits of DEPAKOTE, ask your doctor or pharmacist to let you read the professional labeling and then discuss it with them. If you have any questions or concerns about taking DEPAKOTE, you should discuss them with your doctor.

 Manufactured by Abbott Pharmaceuticals PR Ltd. Barceloneta, PR 00617 Revised 09/2004Manufactured by
Abbott Pharmaceuticals PR Ltd.
Barceloneta, PR 00617

See Full Depakote Prescribing Information

Divalproex birth defects information

Revised 09/2004


The information in this monograph is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects. This information is generalized and is not intended as specific medical advice. If you have questions about the medicines you are taking or would like more information, check with your doctor, pharmacist, or nurse. Last updated 09/-4.

Copyright © 2005 Healthyplace Inc. All rights reserved.

top ~ back to psychiatric medications homepage


 





advertisement

 



HealthyPlace.com Homepage
Chat ~ Forums ~ Communities
HealthyPlace.com Films ~ HealthyPlace.com Radio ~ News
Site Map ~ Web Tour ~ Advertise ~ Email Us
send this page to a friend

© 2000-2008 HealthyPlace.com, Inc. All rights reserved.
Terms of Use Privacy Policy Disclaimer Advertising Policy